HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 1-8-2021 Insider Buy |
Muneer A. Satter See Remarks |
$1.10 CAGR » |
$9,900,000.00 9,000,000 shares |
| 6-8-2020 Insider Buy |
Muneer A. Satter Director and >10% Owner |
$1.10 CAGR » |
$4,070,000.00 3,700,000 shares |
| 9-4-2019 Insider Buy |
Josef H. Von Rickenbach Director |
$0.71 CAGR » |
$16,582.65 23,225 shares |
| 9-3-2019 Insider Buy |
Josef H. Von Rickenbach Director |
$0.72 CAGR » |
$20,395.55 28,466 shares |
| 8-29-2019 Insider Buy |
Josef H. Von Rickenbach Director |
$0.77 CAGR » |
$2,770.92 3,600 shares |
| 8-10-2018 Insider Buy |
John P. Phd Longenecker President and CEO |
$2.45 CAGR » |
$24,500.00 10,000 shares |
| 6-8-2018 Insider Buy |
Donald Dougherty SVP & Chief Financial Officer |
$5.40 CAGR » |
$16,200.00 3,000 shares |
| 7-5-2017 Insider Buy |
IB Investment CO., LTD. Aju >10% Owner |
$15.00 CAGR » |
$373,935.00 24,929 shares |
| 7-5-2017 Insider Buy |
LV Management Group, LLC |
$15.00 CAGR » |
$3,750,000.00 250,000 shares |
| 7-5-2017 Insider Buy |
Armen Shanafelt Director |
$15.00 CAGR » |
$3,750,000.00 250,000 shares |
| 7-5-2017 Insider Buy |
Muneer A. Satter >10% Owner |
$15.00 CAGR » |
$499,995.00 33,333 shares |
| 7-5-2017 Insider Buy |
Medical Fund LP Excel >10% Owner |
$15.00 CAGR » |
$900,000.00 60,000 shares |
| 7-5-2017 Insider Buy |
Emerging Markets LTD. Sigma >10% Owner |
$15.00 CAGR » |
$2,850,000.00 190,000 shares |
| 7-5-2017 Insider Buy |
Brian M. Gallagher Jr. Director |
$15.00 CAGR » |
$4,099,995.00 273,333 shares |
| 7-5-2017 Insider Buy |
Scott Kapnick Director and >10% Owner |
$15.00 CAGR » |
$3,389,595.00 225,973 shares |
| 7-5-2017 Insider Buy |
CVF, LLC >10% Owner |
$15.00 CAGR » |
$2,700,000.00 180,000 shares |
| 7-5-2017 Insider Buy |
Holding Ltd Roche >10% Owner |
$15.00 CAGR » |
$1,791,000.00 119,400 shares |
| 7-5-2017 Insider Buy |
LTD. Kck >10% Owner |
$15.00 CAGR » |
$3,000,000.00 200,000 shares |
| 7-5-2017 Insider Buy |
Bioventures Ltd Novartis >10% Owner |
$15.00 CAGR » |
$4,000,005.00 266,667 shares |
| 1-3-2012 Insider Buy |
Gary Gelman Chairman, President & CEO |
$2.00 CAGR » |
$2,000,000.00 1,000,000 shares |
Also See: Institutional Holders of ALRN
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 01/11/2021 | |
| End date: | 04/22/2024 | |
| Start price/share: | $38.40 | |
| End price/share: | $4.75 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -87.63% | |
| Average Annual Total Return: | -47.16% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $1,236.60 | |
| Years: | 3.28 | |
Aileron Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Aileron Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ALRN
 Free ALRN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the Aileron Therapeutics Insider Buying occurred are:
Auburn National Bancorp Insider Buying
|
